Global Medical REIT (NYSE:XRN) COO Aaron Robert Roseth Purchases 13,500 Shares

Global Medical REIT Inc. (NYSE:XRN) COO Aaron Robert Roseth bought 13,500 shares of the firm’s stock in a transaction on Wednesday, August 12th. The stock was acquired at an average cost of $36.73 per share, with a total value of $495,855.00. Following the completion of the purchase, the chief operating officer owned 13,500 shares of the company’s stock, valued at approximately $495,855. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Global Medical REIT Stock Up 0.7%

Shares of Global Medical REIT stock opened at $36.52 on Friday. The company has a market capitalization of $483.43 million, a P/E ratio of 9.82 and a beta of 1.09. The company has a debt-to-equity ratio of 1.68, a current ratio of 0.68 and a quick ratio of 0.68. The business has a 50-day moving average of $36.59 and a two-hundred day moving average of $35.80. Global Medical REIT Inc. has a 1 year low of $29.05 and a 1 year high of $39.93.

Global Medical REIT (NYSE:XRN) last released its quarterly earnings data on Wednesday, August 5th. The company reported $4.78 earnings per share for the quarter, beating the consensus estimate of $0.83 by $3.95. Global Medical REIT had a return on equity of 13.74% and a net margin of 36.82%.The business had revenue of $39.75 million for the quarter. As a group, equities analysts predict that Global Medical REIT Inc. will post 3.06 EPS for the current year.

Institutional Trading of Global Medical REIT

Several institutional investors and hedge funds have recently bought and sold shares of XRN. Heartland Advisors Inc. boosted its holdings in shares of Global Medical REIT by 177.4% in the 4th quarter. Heartland Advisors Inc. now owns 423,460 shares of the company’s stock valued at $14,288,000 after buying an additional 270,786 shares during the last quarter. Virtus Advisers LLC increased its holdings in Global Medical REIT by 46.5% during the fourth quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock worth $82,000 after buying an additional 768 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its position in Global Medical REIT by 11.4% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 19,600 shares of the company’s stock worth $661,000 after acquiring an additional 2,000 shares in the last quarter. Eurizon Capital SGR S.p.A. acquired a new stake in Global Medical REIT in the fourth quarter valued at $92,000. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Global Medical REIT by 1,001.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock valued at $27,000 after acquiring an additional 721 shares during the last quarter. Institutional investors own 57.52% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on XRN. BMO Capital Markets increased their price objective on shares of Global Medical REIT from $39.00 to $40.00 and gave the stock a “market perform” rating in a research report on Monday, July 13th. Zacks Research raised shares of Global Medical REIT to a “hold” rating in a research report on Wednesday, July 22nd. Citizens Jmp upped their target price on shares of Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research note on Tuesday, May 26th. Weiss Ratings cut Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, July 30th. Finally, Raymond James Financial started coverage on Global Medical REIT in a report on Wednesday, June 17th. They set a “market perform” rating for the company. Two equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $40.25.

Key Global Medical REIT News

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: Insiders purchased roughly $2.54 million of shares over August 10–12. CEO Mark Okey Decker, Jr. bought 15,425 shares in three transactions, COO Aaron Robert Roseth acquired 13,500 shares for approximately $495,855, and director Charles Fitzgerald purchased 41,600 shares worth about $1.49 million. The purchases increase management’s financial exposure to the company and may signal confidence in its outlook. SEC insider purchase filing
• Positive Sentiment: The company’s latest quarterly results were substantially above expectations, with earnings per share of $4.78 versus the $0.83 analyst consensus and revenue of $39.75 million. Global Medical REIT also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for the recent interest in the shares.
• Neutral Sentiment: Analyst sentiment remains mixed. The consensus rating is “Hold,” with two Buy, five Hold and one Sell rating; however, the average price target of $40.25 is above the stock’s recent trading range. Price targets include $42 from Citizens JMP and $38 from Compass Point.
• Neutral Sentiment: A recent article discusses the company’s transition and rebranding to Chiron Real Estate, which could affect how investors interpret the company’s identity and strategy. How Did Chiron Real Estate Emerge From the GMRE Rebrand?
• Negative Sentiment: Global Medical REIT carries elevated leverage, with a debt-to-equity ratio of 1.68, while its quick and current ratios are both 0.68. These figures could limit financial flexibility, particularly if interest rates remain high or property markets weaken.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.